Given the dependence of modern medicine on antimicrobial drugs, and the inevitability of evolution, why is bringing a new antibiotic to market so difficult, and why are so many companies leaving the industry or going bankrupt?
We Can’t Rely on Development of New Drugs Alone to Combat Antimicrobial Resistance
Antimicrobial resistance (AMR) presents a global health crisis, as every day we encounter more infections that cannot be cured with existing antimicrobials. At the same time, the majority of major drug companies have been scaling back or cutting antibiotic research due to development challenges
Policies & Guidelines That Will Help Drive Antimicrobial Stewardship in 2020
Significant action from national and international leadership is needed to encourage and require antimicrobial stewardship programs in healthcare organizations.
Latest CDC Flu View Report Indicates High Flu Activity in Most States
According to the Centers for Disease Control and Prevention’s (CDC) Flu View, seasonal influenza activity in the U.S. is currently high. Thousands have already been hospitalized this season from influenza-associated illnesses and flu activity has continued to increase.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...